Found 2 articles for: "Moderate-to-Severe Plaque Psoriasis"
Effect of Ixekizumab on Patient Reported Outcomes and Quality of Life in Patients With Moderate-to-Severe Plaque Psoriasis: 5-Year Results from the UNCOVER-1 and -2 Studies
April 2021 | Volume 20 | Issue 4 | Original Article | 394 | Copyright © April 2021
Objective: We describe patient-reported outcomes and quality of life through 5 years of treatment in patients with moderate-to-severe plaque Read More
Once-Daily Halobetasol Propionate 0.01% Lotion for Moderate-to-Severe Plaque Psoriasis: Phase 3 Analysis of Hispanic Participants
March 2021 | Volume 20 | Issue 3 | Original Article | 252 | Copyright © March 2021
Background: Psoriasis is a chronic, inflammatory disease that may differ in prevalence and clinical presentation among patients from various racial and ethnic groups. Two phase 3 stud...
Read More
